Apollo Medical Statistics
Share Statistics
Apollo Medical has 44.84M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 44.84M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 823 |
| FTD / Avg. Volume | 0.39% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 29.46 and the forward
PE ratio is null.
Apollo Medical's PEG ratio is
-0.81.
| PE Ratio | 29.46 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| Forward PS | n/a |
| PB Ratio | 2.45 |
| P/FCF Ratio | 22.48 |
| PEG Ratio | -0.81 |
Financial Ratio HistoryEnterprise Valuation
Apollo Medical has an Enterprise Value (EV) of 1.27B.
| EV / Sales | 1.11 |
| EV / EBITDA | 9.54 |
| EV / EBIT | 15.49 |
| EV / FCF | 21.49 |
Financial Position
The company has a current ratio of 2.88,
with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.88 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 3.88 |
| Interest Coverage | 13.16 |
Financial Efficiency
Return on Equity is 8.33% and Return on Invested Capital is 7.13%.
| Return on Equity | 8.33% |
| Return on Assets | 4.68% |
| Return on Invested Capital | 7.13% |
| Revenue Per Employee | $840,060.94 |
| Profits Per Employee | $33,165.2 |
| Employee Count | 1,362 |
| Asset Turnover | 1.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 40.88M |
| Effective Tax Rate | 47.19% |
Stock Price Statistics
The stock price has increased by 2.9% in the
last 52 weeks. The beta is 1.04, so Apollo Medical's
price volatility has been higher than the market average.
| Beta | 1.04 |
| 52-Week Price Change | 2.9% |
| 50-Day Moving Average | 39.06 |
| 200-Day Moving Average | 35.15 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 208,841 |
Income Statement
In the last 12 months, Apollo Medical had revenue of 1.14B
and earned 45.17M
in profits. Earnings per share was 1.
| Revenue | 1.14B |
| Gross Profit | 199.48M |
| Operating Income | 104.27M |
| Net Income | 45.17M |
| EBITDA | 133.35M |
| EBIT | 94.54M |
| Earnings Per Share (EPS) | 1 |
Full Income StatementBalance Sheet
The company has 288.03M in cash and 229.36M in
debt, giving a net cash position of 58.66M.
| Cash & Cash Equivalents | 288.03M |
| Total Debt | 229.36M |
| Net Cash | 58.66M |
| Retained Earnings | 182.42M |
| Total Assets | 1.07B |
| Working Capital | 273.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 82.13M
and capital expenditures -22.94M, giving a free cash flow of 59.19M.
| Operating Cash Flow | 82.13M |
| Capital Expenditures | -22.94M |
| Free Cash Flow | 59.19M |
| FCF Per Share | 1.32 |
Full Cash Flow StatementMargins
Gross margin is 17.43%, with operating and profit margins of 9.11% and 3.95%.
| Gross Margin | 17.43% |
| Operating Margin | 9.11% |
| Pretax Margin | 7.57% |
| Profit Margin | 3.95% |
| EBITDA Margin | 11.65% |
| EBIT Margin | 9.11% |
| FCF Margin | 5.17% |
